| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on December 15, 2006
From the Department of Medicine (V.R.B., H.I., L.D., P.G.Y., D.E.D., S.F., M.F.L.), Pathology (S.F.), and Pharmacology (M.F.L.), Vanderbilt University Medical Center, Nashville, Tenn; Division of Endocrinology and Metabolism (W.J.K.), University of Texas, Dallas, Tex; and Washington University (C.F.S.), St. Louis, Mo. * To whom correspondence should be addressed. E-mail: vladimir.babaev{at}vanderbilt.edu
or sergio.fazio{at}vanderbilt.edu
or macrae.linton{at}vanderbilt.edu.
Background—The peroxisome proliferator–activated receptor- Methods and Results—To examine the contribution of PPAR Conclusions—These data demonstrate that PPAR
Accepted on July 12, 2007
Macrophage Expression of Peroxisome Proliferator–Activated Receptor-
Vladimir R. Babaev PhD*,
Reduces Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient Mice
(PPAR
) plays important roles in lipid metabolism, inflammation, and atherosclerosis. PPAR
ligands have been shown to reduce cardiovascular events in high-risk subjects. PPAR
expression by arterial cells, including macrophages, may exert local antiatherogenic effects independent of plasma lipid changes.
expression by bone marrow–derived cells in atherosclerosis, male and female low-density lipoprotein receptor–deficient (LDLR-/-) mice were reconstituted with bone marrow from PPAR
-/- or PPAR
+/+ mice and challenged with a high-fat diet. Although serum lipids and lipoprotein profiles did not differ between the groups, the size of atherosclerotic lesions in the distal aorta of male and female PPAR
-/-
LDLR-/- mice was significantly increased (44% and 46%, respectively) compared with controls. Male PPAR
-/-
LDLR-/- mice also had larger (44%) atherosclerotic lesions in the proximal aorta than male PPAR
+/+
LDLR-/- mice. Peritoneal macrophages from PPAR
-/- mice had increased uptake of oxidized LDL and decreased cholesterol efflux. PPAR
-/- macrophages had lower levels of scavenger receptor B type I and ABCA1 protein expression and an accelerated response of nuclear factor-
B–regulated inflammatory genes. A laser capture microdissection analysis verified suppressed scavenger receptor B type I and increased nuclear factor-
B gene expression levels in vivo in atherosclerotic lesions of PPAR
-/-
LDLR-/- mice compared with the lesions of control PPAR
+/+
LDLR-/- mice.
expression by macrophages has antiatherogenic effects via modulation of cell cholesterol trafficking and inflammatory activity.
This article has been cited by other articles:
![]() |
A. Amoruso, C. Bardelli, L. G. Fresu, A. Palma, M. Vidali, V. Ferrero, F. Ribichini, C. Vassanelli, and S. Brunelleschi Enhanced Peroxisome Proliferator-Activated Receptor-{gamma} Expression in Monocyte/Macrophages from Coronary Artery Disease Patients and Possible Gender Differences J. Pharmacol. Exp. Ther., November 1, 2009; 331(2): 531 - 538. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Piqueras, M. J. Sanz, M. Perretti, E. Morcillo, L. Norling, J. A. Mitchell, Y. Li, and D. Bishop-Bailey Activation of PPAR{beta}/{delta} inhibits leukocyte recruitment, cell adhesion molecule expression, and chemokine release J. Leukoc. Biol., July 1, 2009; 86(1): 115 - 122. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Rigamonti, G. Chinetti-Gbaguidi, and B. Staels Regulation of Macrophage Functions by PPAR-{alpha}, PPAR-{gamma}, and LXRs in Mice and Men Arterioscler Thromb Vasc Biol, June 1, 2008; 28(6): 1050 - 1059. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |